Lupin Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Lupin Ltd is ₹ 2259 as of 12 May 14:45 . The p/e ratio of Lupin Ltd changed from 38.1 to 28.2 over 5 quarters. This represents a CAGR of -21.39% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The market cap of Lupin Ltd changed from ₹ 46318 crore to ₹ 92522 crore over 5 quarters. This represents a CAGR of 73.94% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The revenue of Lupin Ltd for the Mar '26 is ₹ 7615 crore as compare to the Dec '25 revenue of ₹ 7282 crore. This represent the growth of 4.57% The revenue of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Lupin Ltd for the Mar '26 is ₹ 2494 crore as compare to the Dec '25 ebitda of ₹ 1949 crore. This represent the growth of 27.95% The ebitda of Sanofi India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Lupin Ltd changed from ₹ 805.54 crore to ₹ 1468 crore over 8 quarters. This represents a CAGR of 35.03% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The dividend payout of Lupin Ltd changed from 23.43 % to 13.79 % over 5 quarters. This represents a CAGR of -34.56% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Lupin Ltd

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited.
In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited.
In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Lupin Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Lupin Ltd or Sanofi India Ltd?

Market cap of Lupin Ltd is 102,674 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Lupin Ltd and Sanofi India Ltd?

The stock performance of Lupin Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lupin Ltd and Sanofi India Ltd?

As of May 12, 2026, the Lupin Ltd stock price is INR ₹2245.65. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Lupin Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Lupin Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.